<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Activation of the b-common receptor by erythropoietin impairs acetylcholine-mediated vasodilation in mouse mesenteric arterioles</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Cody</forename><forename type="middle">R</forename><surname>Kilar</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Nephrology</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution" key="instit1">Hypertension, and Transplantation</orgName>
								<orgName type="institution" key="instit2">University of Florida</orgName>
								<address>
									<settlement>Gainesville</settlement>
									<country>Florida</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yanpeng</forename><surname>Diao</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Nephrology</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution" key="instit1">Hypertension, and Transplantation</orgName>
								<orgName type="institution" key="instit2">University of Florida</orgName>
								<address>
									<settlement>Gainesville</settlement>
									<country>Florida</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Larysa</forename><surname>Sautina</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Nephrology</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution" key="instit1">Hypertension, and Transplantation</orgName>
								<orgName type="institution" key="instit2">University of Florida</orgName>
								<address>
									<settlement>Gainesville</settlement>
									<country>Florida</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sivakumar</forename><surname>Sekharan</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Cloud Pharmaceuticals</orgName>
								<address>
									<addrLine>Inc. 6 Davis Dr</addrLine>
									<settlement>Research Triangle Park</settlement>
									<country>North Carolina</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Shahar</forename><surname>Keinan</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Cloud Pharmaceuticals</orgName>
								<address>
									<addrLine>Inc. 6 Davis Dr</addrLine>
									<settlement>Research Triangle Park</settlement>
									<country>North Carolina</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bianca</forename><surname>Carpino</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Nephrology</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution" key="instit1">Hypertension, and Transplantation</orgName>
								<orgName type="institution" key="instit2">University of Florida</orgName>
								<address>
									<settlement>Gainesville</settlement>
									<country>Florida</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kirk</forename><forename type="middle">P</forename><surname>Conrad</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Physiology and Functional Genomics</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution">University of Florida</orgName>
								<address>
									<settlement>Gainesville, Florida</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Obstetrics and Gynecology</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution">University of Florida</orgName>
								<address>
									<settlement>Gainesville, Florida</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rajesh</forename><surname>Mohandas</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Nephrology</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution" key="instit1">Hypertension, and Transplantation</orgName>
								<orgName type="institution" key="instit2">University of Florida</orgName>
								<address>
									<settlement>Gainesville</settlement>
									<country>Florida</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">North Florida</orgName>
								<address>
									<country>South Georgia</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution">Veterans Health System</orgName>
								<address>
									<settlement>Gainesville</settlement>
									<region>Florida</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mark</forename><forename type="middle">S</forename><surname>Segal</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Nephrology</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution" key="instit1">Hypertension, and Transplantation</orgName>
								<orgName type="institution" key="instit2">University of Florida</orgName>
								<address>
									<settlement>Gainesville</settlement>
									<country>Florida</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">North Florida</orgName>
								<address>
									<country>South Georgia</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution">Veterans Health System</orgName>
								<address>
									<settlement>Gainesville</settlement>
									<region>Florida</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">Division of Nephrology</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution" key="instit1">Hypertension, and Transplantation</orgName>
								<orgName type="institution" key="instit2">University of Florida</orgName>
								<address>
									<addrLine>1600 Archer Road</addrLine>
									<postCode>CG-98, 32610</postCode>
									<settlement>Gainesville</settlement>
									<region>FL</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="institution" key="instit1">Sivakumar Sekharan</orgName>
								<orgName type="institution" key="instit2">The Cambridge Crystallographic Data Centre</orgName>
								<address>
									<addrLine>174 Frelinghuysen Road</addrLine>
									<postCode>08854</postCode>
									<settlement>Piscataway</settlement>
									<country>New Jersey</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Activation of the b-common receptor by erythropoietin impairs acetylcholine-mediated vasodilation in mouse mesenteric arterioles</title>
					</analytic>
					<monogr>
						<idno type="ISSN">2051-817X</idno>
					</monogr>
					<idno type="MD5">CACCF76F80A64D1EBB1BA1F8D88DBA4F</idno>
					<idno type="DOI">10.14814/phy2.13751</idno>
					<note type="submission">Received: 29 January 2018; Revised: 26 May 2018; Accepted: 29 May 2018</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:36+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>CD131</term>
					<term>erythropoietin</term>
					<term>hypertension</term>
					<term>b-common receptor</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Clinically, erythropoietin (EPO) is known to increase systemic vascular resistance and arterial blood pressure.</s><s>However, EPO stimulates the production of the potent vasodilator, nitric oxide (NO), in culture endothelial cells.</s><s>The mechanism by which EPO causes vasoconstriction despite stimulating NO production may be dependent on its ability to activate two receptor complexes, the homodimeric EPO (EPOR 2 ) and the heterodimeric EPOR/b-common receptor (bCR).</s><s>The purpose of this study was to investigate the contribution of each receptor to the vasoactive properties of EPO.</s><s>First-order, mesenteric arteries were isolated from 16-week-old male C57BL/6 mice, and arterial function was studied in pressure arteriographs.</s><s>To determine the contribution of each receptor complex, EPO-stimulating peptide (ESP), which binds and activates the heterodimeric EPOR/bCR complex, and EPO, which activates both receptors, were added to the arteriograph chamber 20 min prior to evaluation of endothelium-dependent (acetylcholine, bradykinin, A23187) and endothelium-independent (sodium nitroprusside) vasodilator responses.</s><s>Only ACh-induced vasodilation was impaired in arteries pretreated with EPO or ESP.</s><s>EPO and ESP pretreatment abolished ACh-induced vasodilation by 100% and 60%, respectively.</s><s>EPO and ESP did not affect endothelium-independent vasodilation by SNP.</s><s>Additionally, a novel bCR inhibitory peptide (bIP), which was computationally developed, prevented the impairment of acetylcholine-induced vasodilation by EPO and ESP, further implicating the EPOR/bCR complex.</s><s>Last, pretreatment with either EPO or ESP did not affect vasoconstriction by phenylephrine and KCl.</s><s>Taken together, these findings suggest that acute activation of the heterodimeric EPOR/bCR in endothelial cells leads to a selective impairment of ACh-mediated vasodilator response in mouse mesenteric resistance arteries.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Since the introduction of recombinant erythropoietin (EPO) in the 1980s for treatment of anemia, it has become one of the most widely used cytokines in clinical practice <ref type="bibr" target="#b21">(Jelkmann 1986;</ref><ref type="bibr" target="#b38">T€ ogel et al. 2016)</ref>.</s><s>A common adverse effect of EPO administration is elevation of arterial blood pressure and increase in systemic vascular resistance <ref type="bibr" target="#b17">(Dr€ ueke et al. 2006;</ref><ref type="bibr" target="#b35">Singh et al. 2006;</ref><ref type="bibr" target="#b26">Liu et al. 2011)</ref>.</s><s>While several factors, particularly an increase in erythrocyte mass, were initially postulated to cause EPOinduced hypertension <ref type="bibr" target="#b27">(Martin and Moncada 1988;</ref><ref type="bibr" target="#b19">Fishbane and Besarab 2007)</ref>, a series of experiments by <ref type="bibr" target="#b40">Vaziri et al. (1995)</ref> demonstrated that the hypertensive effects of EPO are independent of its erythropoietic action.</s><s>While the erythropoietic action of EPO is mediated by the homodimeric EPO receptor (EPOR 2 ), EPO also activates a heterodimeric EPOR/b-common receptor (bCR), which is believed to be responsible for the tissue protective effects of EPO <ref type="bibr" target="#b25">(Leist et al. 2004;</ref><ref type="bibr" target="#b33">Sautina et al. 2010;</ref><ref type="bibr" target="#b14">Coldewey et al. 2013;</ref><ref type="bibr" target="#b44">Yang et al. 2013</ref>).</s><s>On one hand, EPO stimulates production of the potent vasodilator, nitric oxide (NO), in cultured bone marrow-derived angiogenic cells (BMDACs) <ref type="bibr" target="#b33">(Sautina et al. 2010</ref>) and endothelial cells <ref type="bibr" target="#b37">(Su et al. 2011)</ref>, via activation of the heterodimeric EPOR/bCR <ref type="bibr" target="#b33">(Sautina et al. 2010</ref>).</s><s>On the other hand, EPO also induces the release of the potent vasoconstrictor endothelin-1 (ET-1) in endothelial cells in vitro <ref type="bibr">(Carlini et al. 1993a,b)</ref>.</s><s>EPO also directly acts on vascular smooth muscle cells to mobilize calcium and facilitate contraction <ref type="bibr" target="#b28">(Morakkabati et al. 1996)</ref>.</s><s>To date, however, it has not been determined if the release of endothelin-1 and effects on smooth muscle cell are mediated by the EPOR 2 or the EPOR/bCR.</s><s>Interestingly, in healthy human subjects, EPO administered intravenously into the brachial artery over a large concentration range impaired cyclooxygenase-dependent vasodilation by acetylcholine in the forearm resistance vasculature without changing in blood pressure <ref type="bibr" target="#b43">(Wada et al. 1999</ref>).</s><s>To our knowledge, there has not been a study to date which identifies whether activation of the homodimeric EPOR 2 , the heterodimeric EPOR/bCR, or both is responsible for the vasoactive effects observed.</s><s>The aim of this study was to evaluate whether the acute vasoactive effects of EPO are mediated by the homodimeric EPOR 2 , the heterodimeric EPOR/bCR, or both.</s><s>To this end, we developed a novel bCR inhibitory peptide (bIP) <ref type="bibr" target="#b23">(Kilar et al. 2018)</ref>, which was extracted from a portion of helix-A from a mutant EPO (PDB code: 1EER, chain A).</s><s>We introduced a double mutation at sites 7 and 11 to the 16-amino acid from the extracted portion of EPO and found the amino acid peptide model comprising of VLERYLHEAKHAEKIT decreases bioavailable nitric oxide and angiogenic potential of the bCR <ref type="bibr" target="#b23">(Kilar et al. 2018)</ref>.</s><s>The use of this peptide allows us to study, in isolation, the effects of EPO on the heterodimer EPOR/bCR.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>The utilization of mice in this study was approved by the Institutional Animal Care and Use Committee at University of Florida and was in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (revised 1996).</s><s>Mice were housed in a 12:12-h light/dark cycle and given access to standard mouse chow and water ad libitum.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Drugs</head><p><s>Acetylcholine (ACh), bradykinin (BK), A23187, sodium nitroprusside (SNP), Tempol, phenylephrine (PE), and potassium chloride (KCl) were obtained from Sigma-Aldrich (St. Louis, MO).</s><s>Human recombinant erythropoietin (EPO) was purchased from Zydus (Cadila, India).</s><s>EPO-stimulating peptide (ESP) derived from a 11-amino acid peptide sequence of the helix B of EPO which interacts with the bCR <ref type="bibr" target="#b7">(Brines et al. 2008</ref>) and the bCR inhibitory peptide (bIP) were synthesized by the core facility <ref type="bibr" target="#b23">(Kilar et al. 2018)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Isobaric arteriography</head><p><s>Sixteen-week-old male C57BL/6 mice were anesthetized with 5% isoflurane/O 2 mix and euthanized by exsanguination.</s><s>The abdominal cavity was opened to expose the mesenteric cascade, which was then isolated and placed in ice-cold HEPES-buffered physiological saline solution (a modified Krebs buffer composed of sodium chloride 142 mmol/L, potassium chloride 4.7 mmol/L, magnesium sulfate 1.17 mmol/L, calcium chloride 2.5 mmol/L, potassium phosphate 1.18 mmol/L, HEPES 10 mmol/L, and glucose 5.5 mmol/L) and maintained at a pH of 7.4 at 37°C.</s><s>With the aid of a dissecting microscope, first-order, mesenteric arterioles were isolated and removed from the surrounding fat as previously described <ref type="bibr" target="#b31">(Novak et al. 2002)</ref>.</s><s>The mesenteric arterioles (unpressurized inner diameter, 100-200 lm) were then transferred to a pressure arteriograph system (Living Systems, Burlington, VT).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Evaluation of endothelium-dependent and endothelium-independent vasodilation</head><p><s>Mesenteric arteries were pretreated with EPO 50 mIU/ mL, ESP 25 ng/mL, or vehicle for 20 min and preconstricted with PE to 50% initial diameter before vasodilatory responses were assessed through the cumulative addition of endothelium-dependent vasodilators ACh (10 À9 -10 À4 mol/L), BK (10 À9 -10 À4 mol/L), A23187 (10 À9 -10 À4 mol/L), and endothelium-independent vasodilator SNP (10 À9 -10 À4 mol/L) to the arteriography chamber.</s><s>Our unpublished data demonstrate that Ach, BK, and A23187 elicit endothelium-dependent vasodilatory effects in first-order mouse mesenteric vessels through an eNOS-dependent pathway.</s><s>Vasodilation was calculated according to the following formula:</s></p><formula xml:id="formula_0">Relaxationð%Þ ¼ ðD s À D b Þ=ðD m À D b Þ Â 100</formula><p><s>where D m is the maximal inner diameter recorded at 60 mmHg in calcium-free HEPES-buffered PSS containing EGTA and papaverine to inhibit vascular smooth muscle function, Ds is the steady-state inner diameter recorded after each addition of the drug, and D b is the initial baseline inner diameter recorded immediately before the first addition of the vasodilatory agent.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Evaluation of vasoconstrictor responses</head><p><s>To determine whether acute pretreatment with EPO, ESP, or vehicle altered vasoconstrictor responsiveness in mesenteric arterioles, concentration-response curves to PE (10 À9 -10 À4 mol/L) and depolarizing concentration of K + (0 mmol/L-100 mmol/L) were evaluated as previously described <ref type="bibr" target="#b29">(Muller-Delp et al. 2002)</ref>.</s><s>Briefly, intraluminal diameters were measured in micrometers at 60 mmHg and expressed as a percentage of vasoconstriction as follows:</s></p><formula xml:id="formula_1">Vasoconstrictionð%Þ ¼ ðD b À D s Þ=D b Â 100</formula><p><s>where D b was the initial baseline intraluminal diameter measured before experimental intervention and D s was the steadystate intraluminal diameter measured after agonist addition.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical and data analysis</head><p><s>Two-way repeated-measures ANOVA was used to detect differences between (vehicle vs. treatment) and within (drug concentrations) factors for the mesenteric resistance artery studies (GraphPad Software, La Jolla, CA).</s><s>All data are presented as means AE SE.</s><s>In all statistical analyses, n indicates the number of animals in each group.</s><s>Student's t-tests were performed to identify differences between the maximal responses (E max ) to ACh, SNP, BK, A23187, KCl, and PE to identify differences in the amount of dilation with respect to intervention, and to determine differences in sensitivity (EC 50 ) to ACh, SNP, BK, A23187, KCl, and PE.</s><s>Significance was defined as P ≤ 0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EPO and ESP impair ACh-mediated endothelium-dependent vasodilation but not endothelium-independent vasodilation by SNP</head><p><s>ACh elicited a maximum vasodilation of ~60% in first-order mesenteric arterioles (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s>However, in vessels pretreated with 50 mIU/mL EPO, the ACh-induced vasodilation was virtually abolished (Fig. <ref type="figure" target="#fig_0">1A</ref>).</s><s>Pretreatment with 25 ng/mL ESP also impaired ACh-induced vasodilation (Fig. <ref type="figure" target="#fig_0">1B</ref>), but to a lesser extent than EPO (by ~60% at 10 À4 mol/L, respectively).</s><s>Importantly, acute pretreatment with EPO or ESP did not alter endothelial-independent vasodilation, maximal response (E max ) or sensitivity (EC 50 ) to SNP (Fig. <ref type="figure">2</ref>), indicating that the two peptides did not interfere with the intrinsic ability of the vascular smooth muscle to vasodilate in response to NO.</s><s>Whether the vessels were obtained from male or female mice, the response to ESP treatment was similar (results not shown).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EPO or ESP-induced impairment of mesenteric resistance artery endotheliumdependent relaxation to ACh is not caused by an increase in oxidative stress</head><p><s>To test whether the compromise of ACh-induced endothelium-dependent vasodilation by EPO and ESP was due to increased reactive oxygen species as previously reported <ref type="bibr" target="#b12">(Chen et al. 1997)</ref>, we employed the O 2 À scavenger Tempol (5 lmol/L).</s><s>Pretreatment with Tempol for 20 min prior to EPO or ESP administration did not affect the inhibition of ACh-induced vasodilation by EPO (Fig. <ref type="figure">3A</ref>) or ESP (Fig. <ref type="figure">3B</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A23187 and bradykinin-induced endothelium-dependent vasodilation is unaffected by acute pretreatment with EPO or ESP</head><p><s>To determine whether the effect of EPO and ESP was unique to ACh, we investigated bradykinin and A23187receptor-mediated and nonreceptor-mediated endothelium-dependent vasodilators, respectively.</s><s>On one hand, ACh and bradykinin receptors both utilize G-protein coupled inositol-1,4,5-trisphosphate (IP 3 ) signaling cascade in endothelial cells to release calcium from endoplasmic reticulum that, in turn, activates K + channels leading to hyperpolarization and calcium influx <ref type="bibr" target="#b5">(Brenner et al. 1989</ref>).</s><s>On the other hand, A23187 directly increases cell permeability to calcium, thereby stimulating eNOS.</s><s>Pretreatment of first-order mesenteric arterioles with EPO or an ESP had no effect on A23187-or bradykinin-induced endothelium-dependent vasodilation suggesting that EPO inhibits ACh-induced vasodilation at the level of muscarinic receptor or muscarinic receptor-G protein interaction (Fig. <ref type="figure" target="#fig_2">4A and B</ref>).</s><s>Additionally, (EC 50 ) and maximal response (E max ) were unaffected in vessels pretreated with EPO or ESP when compared with controls in both A23187-or BK-induced vasodilation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>bIP prevents inhibition of ACh-induced endothelium-dependent vasodilation by EPO or ESP</head><p><s>Pretreatment of mesenteric arteries with bIP blocked the inhibition of ACh-induced vasodilation in vessels by EPO (Fig. <ref type="figure" target="#fig_3">5A</ref>) or ESP (Fig. <ref type="figure" target="#fig_3">5B</ref>).</s><s>Additionally, there was also no significant differences between the sensitivity of EPO (EC 50 = 1.758 9 10 À6 ) or ESP (EC 50 = 2.017 9 10 À6 ) to ACh-induced vasodilation.</s><s>Moreover, the maximal responses (E max ) were also not significantly different.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EPO or ESP does not alter receptordependent or receptor-independent vasoconstriction</head><p><s>Because it has been reported that EPO increases production of potent vasoconstrictors, such as endothelin-1 <ref type="bibr" target="#b42">(Vogel et al. 1997;</ref><ref type="bibr" target="#b1">Barhoumi et al. 2014)</ref>, we explored whether acute pretreatment with EPO or ESP would potentiate vasoconstriction in first-order mesenteric arteries.</s><s>Neither EPO nor ESP, however, affected vasoconstriction by PE (Fig. <ref type="figure">6A and C</ref>) or KCl (Fig. <ref type="figure">6B and D</ref>).</s><s>Additionally, EPO or ESP did not alter the sensitivity (EC 50 ) or maximal response (E max ) of the vasoconstrictors PE or KCl.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>There are several new findings that emerged from this research: (1) acute activation of the bCR with EPO or ESP in mouse mesenteric arteries inhibited ACh, but not BK or A23187 endothelium-dependent vasodilation, and this inhibition of ACh was blocked by a novel bCR inhibitor, bIP;</s></p><p><s>(2) impaired ACh-induced vasodilation by EPO and ESP did not appear to be due to generation of reactive oxygen species; and (3) activation of the bCR by either EPO or ESP did not affect mesenteric vessel vasoconstriction to PE and KCl.</s><s>Our results suggest that activation of the bCR on the vascular endothelium with EPO or ESP specifically impairs endothelial vasodilatory responses to ACh, which may contribute to the pathogenesis of EPO-induced hypertension.</s></p><p><s>Animal models have been utilized to try to investigate the clinical observation of EPO-induced hypertension <ref type="bibr" target="#b40">(Vaziri et al. 1995</ref><ref type="bibr" target="#b41">(Vaziri et al. , 1996;;</ref><ref type="bibr" target="#b34">Schiffl and Lang 1997;</ref><ref type="bibr" target="#b39">Vaziri 1999)</ref>.</s><s>Animals given high doses of EPO exhibit a marked increase in hemoglobin concentration <ref type="bibr" target="#b39">(Vaziri 1999;</ref><ref type="bibr" target="#b35">Singh et al. 2006;</ref><ref type="bibr" target="#b19">Fishbane and Besarab 2007)</ref>, as well as increased systemic vascular resistance <ref type="bibr" target="#b2">(Becker et al. 2016</ref>) and blood pressure <ref type="bibr" target="#b8">(Buemi et al. 1995;</ref><ref type="bibr" target="#b22">Kanbay et al. 2007;</ref><ref type="bibr" target="#b2">Becker et al. 2016</ref>) similar to patients.</s><s>In addition to increased systemic vascular resistance and blood pressure, small resistance arteries demonstrate diminished endothelium-dependent vasodilation to ACh <ref type="bibr" target="#b8">(Buemi et al. 1995;</ref><ref type="bibr" target="#b30">Noguchi et al. 2001;</ref><ref type="bibr" target="#b0">Annuk et al. 2006;</ref><ref type="bibr" target="#b6">Briet et al. 2013)</ref>.</s><s>However, there are no reports on whether EPO treatment differentially affects receptor-and nonreceptormediated endothelium-dependent vasodilation, and if so, which of the EPO receptor dimeric complexes might be involved.</s><s>Our data demonstrate that after short-term incubation with EPO or an ESP, ACh-induced vasodilation is selectively impaired via the EPOR/bCR heterodimeric receptor (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s><ref type="bibr" target="#b6">Briet et al. (2013)</ref> demonstrated that oxidative stress plays a role in EPO-induced hypertension in humans, and in gluteal subcutaneous resistance arteries isolated from these patients, Tempol restored endothelial function.</s><s>However, in our model, Tempol did not ameliorate the inhibition of ACh-mediated vasodilation by EPO or ESP in isolated mouse mesenteric arteries (Fig. <ref type="figure">3</ref>), suggesting that the impairment was not due to increased reactive oxygen species.</s><s>Although there are many potential explanations for these discrepant results, one possibility is the marked difference in the duration of arterial exposure to EPO (months in vivo vs. minutes in vitro).</s></p><p><s>We further demonstrated an essential role for the bCR in the impairment of ACh-mediated vasodilation by EPO, insofar as ESP, which specifically agonizes the bCR/ EPOR 2 heterodimer and does not stimulate erythropoiesis, duplicated the inhibitory action of EPO, albeit perhaps to a lesser degree.</s><s>To our knowledge, there are limited reports of the involvement of this receptor in endothelial function <ref type="bibr" target="#b37">(Su et al. 2011)</ref>.</s><s>We confirmed the critical role of bCR by using a novel inhibitor of bCR (bIP), which acts as a competitive inhibitor of ligand binding to bCR.</s><s>bIP abrogated the ability of EPO and ESP to inhibit the vasodilatory effect of ACh.</s><s>Interestingly, EPO and ESP had similar sensitivities (EC 50 ) to ACh after treatment with bIP, suggesting that activation of the bCR is responsible for decreasing the vasoactive response to ACh.</s></p><p><s>The mechanisms by which EPO compromises AChmediated endothelium-dependent vasodilation is unknown.</s><s>Using immunoprecipitation and immunofluorescence, our group reported co-localization of bCR and vascular endothelial growth factor receptor 2 (VEGFR-2) in human bone marrow-derived angiogenic cells (BMDACs) <ref type="bibr" target="#b33">(Sautina et al. 2010)</ref>, and other investigators also reported that muscarinic acetylcholine receptor (mAChR) has a physical interaction with VEGFR-2 in human neuroblastoma cells <ref type="bibr" target="#b18">(Edelstein et al. 2011</ref>).</s><s>Furthermore, both VEGFR-2 and mAChR have been shown to localize in caveolae <ref type="bibr" target="#b32">(Rybin et al. 2000;</ref><ref type="bibr" target="#b13">Cho et al. 2004;</ref><ref type="bibr" target="#b36">Sonveaux et al. 2004;</ref><ref type="bibr" target="#b24">Lampugnani et al. 2006)</ref>.</s><s>Taken together, these findings raise the possibility that bCR and the muscarinic acetylcholine receptor 2 (mAChR2) are co-localized in the endothelial caveolae.</s><s>It has been suggested that once activated, the bCR is internalized to elicit its downstream responses <ref type="bibr" target="#b16">(Debeljak et al. 2014)</ref>.</s><s>However, there is no experimental evidence to support this mechanism.</s><s>Further studies are needed to determine if bCR is associated with the caveolae in endothelial cells, and if so, whether activation leads to internalization.</s><s>How this might lead to impairment of ACh-mediated endothelium-dependent vasodilation also requires further investigation.</s><s>Carlini <ref type="bibr">et al. (1993b)</ref> have shown that animals treated with EPO have increased expression of ET-1 <ref type="bibr" target="#b37">(Su et al. 2011)</ref>.</s><s>Also, EPO administration to patients with anemia lead to increased production of cyclooxygenase-dependent vasoconstrictors in forearm-resistance arteries <ref type="bibr" target="#b9">(Carlini et al. 1993a)</ref>.</s><s><ref type="bibr" target="#b3">Bode-B€ oger et al. (1996)</ref> described that acute EPO treatment significantly enhanced noradrenaline-induced vasoconstriction in rabbit aorta and carotid arteries.</s><s>However, our data suggest that after acute treatment in vitro, EPO does not potentiate vasoconstrictor responses in mouse mesenteric arteries or reduce baseline internal diameter, thus mitigating against a role for cyclooxygenase-generated vasoconstrictors.</s><s>One major difference between the studies described above and this current study is the concentration of EPO used for experimentation, which was 100-1000 times the concentration that was used in this study <ref type="bibr" target="#b3">(Bode-B€ oger et al. 1996)</ref>.</s></p><p><s>In summary, we demonstrated that activation of the bCR leads to impairment of ACh-induced vasodilation, which is prevented by a novel bIP.</s><s>To our knowledge, this is the first study showing that activation of the bCR affects vasoreactivity.</s><s>In the current literature, little evidence exists for the role of the bCR on the vasculature <ref type="bibr" target="#b4">(Bohr et al. 2013)</ref>.</s><s>bCR knockout mice appears to have normal development and, as would be expected, normal erythropoiesis <ref type="bibr" target="#b33">(Sautina et al. 2010;</ref><ref type="bibr" target="#b20">Hand and Brines 2011;</ref><ref type="bibr" target="#b11">Cerami 2012;</ref><ref type="bibr" target="#b16">Debeljak et al. 2014;</ref><ref type="bibr" target="#b15">Collino et al. 2015)</ref>.</s><s>However, investigation of blood pressure and arterial function has not been reported.</s><s>It would also be interesting to test whether bIP attenuates EPO-induced hypertension in experimental animal models.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Effect of EPO or the ESP on ACh-induced vasodilation of first-order mesenteric arterioles.</s><s>First-order mesenteric arteries were acutely pretreated with (A) EPO (50 mIU/mL) or (B) ESP (25 ng/mL) for 20 min before assessment of ACh-induced endotheliumdependent vasodilation.</s><s>All values are means AE SE. n equals the number of animals studied.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .Figure 3 .</head><label>23</label><figDesc><div><p><s>Figure 2. Effect of EPO and the ESP sodium nitroprusside (SNP)induced vasodilation.</s><s>First-order mesenteric arteries were acutely pretreated with (A) EPO (50 mIU/mL) or (B) ESP (25 ng/mL) for 20 min before assessment of SNP-induced endotheliumindependent vasodilation.</s><s>All values are means AE SE. n equals the number of animals studied.</s><s>Responses were not different between groups.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4. EPO or ESP had no effect on endothelium-dependent relaxation to A23187 or BK.</s><s>First-order mesenteric arteries subjected to acute pretreatment of EPO (50 mIU/mL) (A, C) or an ESP (25 ng/mL) (B, D) before endothelium-dependent vasodilators A23187 and BK were assessed.</s><s>All values are means AE SE. n equals the number of animals studied.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 5 .</head><label>5</label><figDesc><div><p><s>Figure5.</s><s>Novel bIP restores ablated ACh-induced endotheliumdependent vasodilation.</s><s>First-order mesenteric arteries were treated with the bIP (10 lmol/L) for 30 min prior to being acutely pretreated with (A) EPO (50 mIU/mL) or (B) ESP (25 ng/mL) for 20 min.</s><s>ACh-induced endothelium-dependent vasodilation was then assessed.</s><s>Sensitivity of EPO (EC 50 = 1.758 9 10 À6 ) or ESP (EC 50 = 2.017 9 10 À6 ) was not reduced when compared with vehicle or when compared with one another.</s><s>All values are means AE SE. n equals the number of animals studied.</s><s>Responses were not different between groups.</s></p></div></figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf ofThe Physiological Society and the American Physiological Society.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of Interest</head><p><s>None declared.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Erythropoietin impairs endothelial vasodilatory function in patients with renal anemia and in healthy subjects</title>
		<author>
			<persName><forename type="first">M</forename><surname>Annuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Linde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lind</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fellstr€</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nephron Clin. Pract</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="30" to="34" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Erythropoietin-induced hypertension and vascular injury in mice overexpressing human endothelin-1: exercise attenuated hypertension, oxidative stress, inflammation and immune response</title>
		<author>
			<persName><forename type="first">T</forename><surname>Barhoumi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Briet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Kasal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Fraulob-Aquino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Idris-Khodja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Laurant</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Hypertens</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="784" to="794" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Erythropoietin recapitulates hemodynamic features of hypoxia-induced pulmonary hypertension in mice</title>
		<author>
			<persName><forename type="first">J</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Peter-Thiebaut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">El</forename><surname>Fertak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Denu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Reilly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. Respiratory Soc</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page">A5097</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Bode-B€ Oger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>B€ Oger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kuhn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Radermacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Fr€</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="1255" to="1261" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Alternative erythropoietin-mediated signaling prevents secondary microvascular thrombosis and inflammation within cutaneous burns</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bohr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Vitalo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brines</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cerami</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="3513" to="3518" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Endothelium-dependent vascular responses. Mediators and mechanisms</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Brenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Troy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Ballermann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="1373" to="1378" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Effects of recombinant human erythropoietin on resistance artery endothelial function in stage 4 chronic kidney disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Briet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Barhoumi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Mian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sierra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Boutouyrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Davidman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Am. Heart Assoc</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">e000128</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin</title>
		<author>
			<persName><forename type="first">M</forename><surname>Brines</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Villa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Brines</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mennini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">De</forename><surname>Paola</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="10925" to="10930" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Recombinant human erythropoietin inhibits the cutaneous vasodilatation induced by acetylcholine</title>
		<author>
			<persName><forename type="first">M</forename><surname>Buemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Denuzzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Allegra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Aloisi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Squadrito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Squadrito</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Microcirc. Clin. Exp</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="283" to="286" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients</title>
		<author>
			<persName><forename type="first">R</forename><surname>Carlini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Obialo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rothstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hypertens</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="103" to="107" />
			<date type="published" when="1993">1993a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Carlini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Dusso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Obialo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">M</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rothstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1010" to="1014" />
			<date type="published" when="1993">1993b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">TNF and EPO: major players in the innate immune response: their discovery</title>
		<author>
			<persName><forename type="first">A</forename><surname>Cerami</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Rheum. Dis</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="55" to="59" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Recombinant human erythropoietin enhances superoxide production by FMLP-stimulated polymorphonuclear leukocytes in hemodialysis patients</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Lai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="1390" to="1394" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Localization of VEGFR-2 and PLD2 in endothelial caveolae is involved in VEGF-induced phosphorylation of MEK and ERK</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Jang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hwang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Physiol. Heart Circ. Physiol</title>
		<imprint>
			<biblScope unit="volume">286</biblScope>
			<biblScope unit="page" from="H1881" to="1888" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the b-common receptor</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Coldewey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kapoor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Collino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rogazzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brines</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="482" to="490" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a nonerythropoietic small peptide engineered from erythropoietin</title>
		<author>
			<persName><forename type="first">M</forename><surname>Collino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Thiemermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cerami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brines</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol. Ther</title>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="page" from="32" to="40" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Erythropoietin and cancer: the unintended consequences of anemia correction</title>
		<author>
			<persName><forename type="first">N</forename><surname>Debeljak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Sytkowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front Immunol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">563</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Normalization of hemoglobin level in patients with chronic kidney disease and anemia</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Dr€ Ueke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Locatelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Clyne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">U</forename><surname>Eckardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Macdougall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tsakiris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">355</biblScope>
			<biblScope unit="page" from="2071" to="2084" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Crosstalk between VEGFR2 and muscarinic receptors regulates the mTOR pathway in serum starved SK-N-SH human neuroblastoma cells</title>
		<author>
			<persName><forename type="first">J</forename><surname>Edelstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Morales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rockwell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell. Signal</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="239" to="248" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets</title>
		<author>
			<persName><forename type="first">S</forename><surname>Fishbane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Besarab</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. J. Am. Soc. Nephrol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1274" to="1282" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Hand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brines</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Investig. Med</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="1073" to="1082" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Erythropoietin research, 80 years after the initial studies by Carnot and Deflandre</title>
		<author>
			<persName><forename type="first">W</forename><surname>Jelkmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Respir. Physiol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="257" to="266" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Comparison of effects of darbepoetin alfa and epoetin alfa on serum endothelin level and blood pressure</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kanbay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Akcay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Delibasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Uz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Koca</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv. Ther</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="346" to="352" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Computational design and experimental characterization of a novel b-common receptor inhibitory peptide</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Kilar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sekharan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sautina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Diao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Keinan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Lampugnani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Orsenigo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Gagliani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tacchetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Dejana</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">174</biblScope>
			<biblScope unit="page" from="593" to="604" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Derivatives of erythropoietin that are tissue protective but not erythropoietic</title>
		<author>
			<persName><forename type="first">M</forename><surname>Leist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ghezzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Grasso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bianchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Villa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fratelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">305</biblScope>
			<biblScope unit="page" from="239" to="242" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Erythropoietin increases expression and function of transient receptor potential canonical 5 channels</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Thilo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">G</forename><surname>Friis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scholze</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="317" to="324" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Blood pressure, erythropoietin, and nitric oxide</title>
		<author>
			<persName><forename type="first">J</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Moncada</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">644</biblScope>
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Erythropoietin induces Ca 2+ mobilization and contraction in rat mesangial and aortic smooth muscle cultures</title>
		<author>
			<persName><forename type="first">N</forename><surname>Morakkabati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gollnick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fandrey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Jelkmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp. Hematol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="392" to="397" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Effects of aging on vasoconstrictor and mechanical properties of rat skeletal muscle arterioles</title>
		<author>
			<persName><forename type="first">J</forename><surname>Muller-Delp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Spier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Ramsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Lesniewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Papadopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Humphrey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Physiol. Heart Circ. Physiol</title>
		<imprint>
			<biblScope unit="volume">282</biblScope>
			<biblScope unit="page" from="H1843" to="1854" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Effect of 1-week treatment with erythropoietin on the vascular endothelial function in anaesthetized rabbits</title>
		<author>
			<persName><forename type="first">K</forename><surname>Noguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yamashiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Matsuzaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sakanashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nakasone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miyagi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. J. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="395" to="405" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Myogenic reactivity is reduced in small renal arteries isolated from relaxin-treated rats</title>
		<author>
			<persName><forename type="first">J</forename><surname>Novak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Ramirez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Gandley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">D</forename><surname>Sherwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Conrad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Physiol. Regul. Integr. Comp. Physiol</title>
		<imprint>
			<biblScope unit="volume">283</biblScope>
			<biblScope unit="page" from="R349" to="355" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">O</forename><surname>Rybin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Lisanti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Steinberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="41447" to="41457" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Induction of nitric oxide by erythropoietin is mediated by the beta common receptor and requires interaction with VEGF receptor 2</title>
		<author>
			<persName><forename type="first">L</forename><surname>Sautina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sautin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Beem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schuler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Brennan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="896" to="905" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Hypertension induced by recombinant human erythropoietin (rHU-EPO) can be prevented by indomethacin. Pathogenetic role of cytosolic calcium</title>
		<author>
			<persName><forename type="first">H</forename><surname>Schiffl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Lang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Med. Res</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="97" to="100" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Correction of anemia with epoetin alfa in chronic kidney disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Szczech</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Barnhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wolfson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">355</biblScope>
			<biblScope unit="page" from="2085" to="2098" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Sonveaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Martinive</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dewever</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Batova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Daneau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pelat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ. Res</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="154" to="161" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">b Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Shyue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">R</forename><surname>Kou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Ching</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Chiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">B</forename><surname>Yu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell. Physiol</title>
		<imprint>
			<biblScope unit="volume">226</biblScope>
			<biblScope unit="page" from="3330" to="3339" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Carbamylated erythropoietin outperforms erythropoietin in the treatment of AKI-on-CKD and Other AKI Models</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>T€ Ogel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Ahlstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Westenfelder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Am. Soc. Nephrol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="3394" to="3404" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Mechanism of erythropoietin-induced hypertension</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Vaziri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="821" to="828" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">In vivo and in vitro pressor effects of erythropoietin in rats</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Vaziri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Oveisi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Baldwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Purdy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Physiol</title>
		<imprint>
			<biblScope unit="volume">269</biblScope>
			<biblScope unit="page" from="F838" to="845" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Vaziri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Naqvi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Oveisi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">Q</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Physiol</title>
		<imprint>
			<biblScope unit="volume">271</biblScope>
			<biblScope unit="page" from="E113" to="122" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Effects of erythropoietin on endothelin-1 synthesis and the cellular calcium messenger system in vascular endothelial cells</title>
		<author>
			<persName><forename type="first">V</forename><surname>Vogel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Kramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Acker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Meyer-Lehnert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Jelkmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fandrey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hypertens</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="289" to="296" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Erythropoietin impairs endotheliumdependent vasorelaxation through cyclooxygenasedependent mechanisms in humans</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Matsuoka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Tamai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Okuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Imaizumi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hypertens</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="980" to="987" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Helix B surface peptide administered after insult of ischemia reperfusion improved renal function, structure and apoptosis through beta common receptor/erythropoietin receptor and PI3K/Akt pathway in a murine model</title>
		<author>
			<persName><forename type="first">C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp. Biol. Med. (Maywood)</title>
		<imprint>
			<biblScope unit="volume">238</biblScope>
			<biblScope unit="page" from="111" to="119" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<title level="m" type="main">The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the</title>
		<imprint>
			<date type="published" when="2018">2018</date>
			<publisher>American Physiological Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
